ATUL

5,747.25
-50.65
(-0.87%)
Market Cap
16,920.91 Cr
EPS
109.54
PE Ratio
40.95
Dividend Yield
0.35 %
Industry
Chemicals
52 Week High
8,180.00
52 Week Low
5,149.55
PB Ratio
3.04
Debt to Equity
0.03
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from9 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy+44.44 %
+44.44 %
Hold+33.33 %
+33.33 %
Sell+22.22 %
+22.22 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
2,872.75
#1 1,46,121.73
72.68
12,522.60
#1 5.69
#1 1,747
9.04
63.39
2,944.25
87,274.88
76.00
13,221.50
-11.53
1,336
6.99
55.60
4,001.00
43,950.99
96.50
4,387.70
-25.09
435
57.50
63.97
1,980.30
27,009.91
39.29
7,757.90
-3.26
811
-51.46
44.92
427.55
21,107.34
41.15
4,227.40
0.66
411
29.69
47.90
4,199.00
20,815.92
79.21
2,120.90
0.37
271
7.18
60.10
4,430.90
19,179.43
#1 32.04
#1 13,843.30
-
563
-26.05
46.39
1,570.35
16,279.13
42.39
1,938.80
-8.77
323
21.85
45.18
393.55
14,266.97
39.26
6,380.70
-3.61
417
-62.90
45.77
ATUL
this company
5,747.25
#8 16,920.91
#4 40.95
#6 4,783.90
#8 -13.69
#8 324
#1 62.41
51.48
Growth Rate
Revenue Growth
-13.69 %
Net Income Growth
-36.02 %
Cash Flow Change
-5.55 %
ROE
-41.53 %
ROCE
-41.50 %
EBITDA Margin (Avg.)
-9.47 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
929
1,057
1,028
1,064
1,052
1,068
1,055
1,002
702
1,011
993
1,137
1,112
1,273
1,386
1,395
1,514
1,521
1,291
1,221
1,192
1,218
1,155
1,228
1,338
1,428
1,436
Expenses
762
836
818
855
800
821
792
777
502
741
710
862
844
1,031
1,129
1,165
1,244
1,267
1,096
1,046
1,000
1,039
986
1,065
1,099
1,150
1,193
EBITDA
167
221
210
209
251
247
263
225
200
270
283
275
268
241
257
229
270
254
195
175
192
180
169
164
240
277
243
Operating Profit %
17 %
19 %
21 %
19 %
23 %
21 %
24 %
19 %
24 %
26 %
26 %
23 %
22 %
17 %
18 %
15 %
16 %
15 %
14 %
13 %
15 %
13 %
13 %
12 %
17 %
17 %
16 %
Depreciation
28
29
29
33
32
32
32
34
33
33
33
37
43
44
45
44
47
49
50
51
52
54
61
76
77
78
81
Interest
2
2
2
2
2
2
3
2
3
2
2
2
2
2
2
3
2
2
2
2
2
2
2
5
5
9
4
Profit Before Tax
137
190
179
174
218
212
227
188
164
235
247
236
222
196
210
182
221
203
142
122
139
124
105
83
158
191
158
Tax
54
67
63
61
69
2
57
46
46
60
57
59
57
50
53
45
58
54
39
30
36
33
33
24
46
51
41
Net Profit
83
124
117
113
149
210
170
143
118
175
190
177
165
146
157
137
164
148
103
92
102
91
72
59
112
140
117
EPS in ₹
27.44
41.21
39.46
37.61
49.67
70.45
56.95
47.62
39.71
58.78
63.58
59.04
56.09
49.56
52.53
46.05
55.70
51.11
35.60
31.69
35.02
30.60
24.04
19.81
38.00
46.47
36.93

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,823
2,479
2,727
3,014
3,544
4,151
4,937
5,706
5,768
6,476
Fixed Assets
514
753
1,026
1,027
1,104
1,110
1,402
1,617
1,750
2,771
Current Assets
1,041
1,059
1,127
1,356
1,662
2,082
2,564
2,689
2,091
2,276
Capital Work in Progress
112
180
59
96
172
368
250
421
1,033
281
Investments
3
379
429
470
752
1,137
1,361
1,339
881
1,392
Other Assets
1,195
1,167
1,213
1,420
1,515
1,535
1,925
2,331
2,104
2,032
Total Liabilities
1,823
2,479
2,727
3,014
3,544
4,151
4,937
5,706
5,768
6,476
Current Liabilities
638
706
588
569
577
732
806
999
840
888
Non Current Liabilities
140
156
158
181
237
237
274
248
208
425
Total Equity
1,045
1,617
1,981
2,264
2,730
3,181
3,857
4,460
4,719
5,163
Reserve & Surplus
1,009
1,585
1,936
2,214
2,676
3,125
3,797
4,399
4,642
5,085
Share Capital
30
30
30
30
30
30
30
30
30
30

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
16
-13
5
19
-5
-11
21
11
-20
22
Investing Activities
-167
-375
-175
-129
-408
-782
-645
-163
-469
-683
Operating Activities
306
401
392
356
404
881
718
231
707
668
Financing Activities
-124
-39
-212
-207
-1
-111
-52
-57
-258
38

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
44.93 %
44.93 %
44.94 %
44.94 %
44.94 %
45.05 %
45.05 %
45.06 %
45.06 %
45.06 %
45.06 %
45.07 %
45.17 %
45.17 %
45.17 %
45.17 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
7.71 %
8.06 %
8.47 %
8.63 %
9.67 %
11.22 %
DIIs
23.02 %
22.23 %
21.96 %
21.87 %
23.10 %
22.98 %
22.95 %
24.22 %
25.23 %
25.73 %
26.51 %
26.08 %
25.68 %
25.82 %
24.54 %
22.79 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
18.28 %
18.21 %
18.40 %
18.53 %
18.20 %
18.20 %
17.80 %
17.30 %
16.90 %
16.69 %
16.28 %
16.03 %
16.41 %
16.35 %
16.59 %
16.56 %
Others
13.77 %
14.62 %
14.70 %
14.66 %
13.76 %
13.76 %
14.19 %
13.42 %
12.81 %
12.52 %
4.45 %
4.76 %
4.27 %
4.03 %
4.03 %
4.26 %
No of Share Holders
50,197
54,214
59,726
67,025
64,429
69,679
70,248
66,455
67,542
68,751
66,776
65,757
66,589
67,753
60,354
59,110

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 10 12 15 27.5 20 25 32.5 20 0.00
Dividend Yield (%) 0.00 0.38 0.33 0.38 0.39 0.19 0.36 0.57 0.34 0.00

Corporate Action

Announcements

Closure of Trading Window1 day ago
Board Meeting Intimation for Audited Standalone And Consolidated Financial Results And Dividend For The Year Ended On March 31 20251 day ago
Announcement under Regulation 30 (LODR)-Retirement2 days ago
Update On Valsad Institute Of Medical Sciences LtdFeb 13, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 06, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 04, 2025
Communication To The Members Of The Company Regarding Financial Results And Investors Presentation For The Third Quarter And Nine Months Ended On December 31 2024Jan 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 25, 2025
Integrated Filing (Financial)Jan 24, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJan 24, 2025
Financial ResultsJan 24, 2025
Letter AttachedJan 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Intimation Regarding Change Of Name Of Link Intime India Private Limited Registrar And Share Transfer Agent Of The CompanyJan 02, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementDec 16, 2024
Transfer Of Equity Shares To The Investor Education And Protection FundNov 30, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 29, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 27, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 21, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 05, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011Oct 29, 2024
Revision In Our Letter Dated October 29, 2024 - Increase In Capacity Of Liquid Epoxy ResinOct 29, 2024
Increase In Capacity Of Liquid Epoxy ResinOct 29, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 26, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationOct 25, 2024
Financial Results For Second Quarter And Six Months Ended On September 30, 2024Oct 25, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementOct 15, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 09, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 08, 2024
Closure of Trading WindowSep 25, 2024
Board Meeting Intimation for Financial Results For The Second Quarter / Six Months Ending On September 30, 2024Sep 25, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 20, 2024
Disclosure Under Regulation 30 Of SEBI LODRSep 10, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateSep 05, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 29, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 10, 2024
Update On The Establishment Inspection Report (EIR) From The United States Food And Drug Administration (USFDA) - Press ReleaseAug 09, 2024
Speech Delivered By The Chairman And Managing Director At The 47Th Annual General MeetingAug 08, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateAug 01, 2024
Audiovisual Of Proceedings Of The 47Th Annual General MeetingJul 29, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportJul 26, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 26, 2024
Integrated Annual Report 2023-24Jul 25, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJul 25, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 22, 2024
Unaudited Financial ResultsJul 19, 2024
Business Responsibility and Sustainability Reporting (BRSR)Jul 15, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateJul 08, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 05, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 05, 2024

Technical Indicators

RSI(14)
Neutral
51.48
ATR(14)
Less Volatile
193.12
STOCH(9,6)
Neutral
67.45
STOCH RSI(14)
Neutral
61.03
MACD(12,26)
Bullish
50.16
ADX(14)
Strong Trend
29.92
UO(9)
Bearish
49.50
ROC(12)
Uptrend And Accelerating
1.94
WillR(14)
Neutral
-40.20

About ATUL

Atul Limited is a diversified Indian company part of the Lalbhai Group. It primarily operates in Life Science Chemicals and Performance and Other Chemicals, serving various industries worldwide. The company manufactures products such as dyes, dye intermediates, agro-chemicals, aromatics, epoxy resins, and pharma intermediates. Atul has established subsidiaries in the USA, UK, China, Brazil, and UAE to enhance its global presence. The company has multiple manufacturing facilities in India and has implemented various environmental initiatives, including achieving zero liquid effluent discharge in some facilities. Atul has engaged in joint ventures, acquisitions, and expansions to grow its business. It has also focused on research and development, introducing new products and improving existing processes. The company operates through three main segments: Life Science Chemicals, Performance and Other Chemicals, and Others, offering a wide range of products including APIs, crop protection chemicals, adhesion promoters, bulk chemicals, epoxy resins, textile dyes, and agribiotech services.
Chairperson NameS S Lalbhai